IDXX IDEXX Laboratories, Inc. Stock Quote

IDXX [NASD]

Healthcare | Diagnostics & Research | USA

Index	S&P 500	P/E	76.13	EPS (ttm)	8.38	Insider Own	0.90%	Shs Outstand	85.33M	Perf Week	4.16%
Market Cap	53.84B	Forward P/E	68.06	EPS next Y	9.38	Insider Trans	-11.10%	Shs Float	84.27M	Perf Month	-3.54%
Income	727.80M	PEG	3.83	EPS next Q	1.91	Inst Own	87.80%	Short Float	0.94%	Perf Quarter	-4.65%
Sales	3.05B	P/S	17.67	EPS this Y	37.30%	Inst Trans	0.09%	Short Ratio	2.01	Perf Half Y	19.92%
Book/sh	8.76	P/B	72.86	EPS next Y	11.92%	ROA	32.10%	Target Price	717.50	Perf Year	50.63%
Cash/sh	2.75	P/C	231.97	EPS next 5Y	19.90%	ROE	115.40%	52W Range	416.48 - 706.95	Perf YTD	27.69%
Dividend	-	P/FCF	77.55	EPS past 5Y	26.70%	ROI	39.90%	52W High	-9.71%	Beta	0.93
Dividend %	-	Quick Ratio	1.20	Sales past 5Y	11.10%	Gross Margin	58.80%	52W Low	53.26%	ATR	15.95
Employees	9300	Current Ratio	1.50	Sales Q/Q	29.60%	Oper. Margin	28.40%	RSI (14)	49.35	Volatility	1.64% 2.45%
Optionable	Yes	Debt/Eq	1.21	EPS Q/Q	35.60%	Profit Margin	23.90%	Rel Volume	0.63	Prev Close	635.15
Shortable	Yes	LT Debt/Eq	1.04	Earnings	Nov 02 BMO	Payout	0.00%	Avg Volume	394.27K	Price	638.29
Recom	2.40	SMA20	0.40%	SMA50	-3.20%	SMA200	10.35%	Volume	247,400	Change	0.49%

Aug-05-21

Resumed

Credit Suisse

Outperform

$735

Jul-12-21

Downgrade

Guggenheim

Buy → Neutral

Feb-17-21

Initiated

Barclays

Overweight

$600

Sep-09-19

Initiated

Goldman

Neutral

$277

May-23-19

Initiated

Guggenheim

Buy

$276

Nov-02-18

Reiterated

BofA/Merrill

Buy

$275 → $235

May-07-18

Reiterated

Stifel

Buy

$215 → $225

Jan-16-18

Initiated

Piper Jaffray

Overweight

$200

Aug-23-17

Upgrade

BofA/Merrill

Neutral → Buy

Jul-28-17

Upgrade

CL King

Neutral → Buy

Feb-03-17

Downgrade

Feltl & Co.

Hold → Sell

Sep-29-16

Resumed

BofA/Merrill

Neutral

Aug-16-16

Reiterated

Stifel

Buy

$120 → $125

Aug-03-16

Upgrade

Northcoast

Sell → Neutral

Jul-20-16

Reiterated

Canaccord Genuity

Buy

$90 → $98

Apr-19-16

Reiterated

Canaccord Genuity

Buy

$80 → $85

Apr-01-16

Initiated

CL King

Neutral

Mar-21-16

Reiterated

Stifel

Buy

$80 → $85

Feb-04-16

Initiated

Credit Suisse

Outperform

Oct-29-15

Reiterated

Stifel

Buy

$85 → $80

Oct-18-21 09:48AM	Here's Why I Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today Simply Wall St.
Oct-14-21 01:25PM	Replay: Goldman-Backed Nuclear Analytics: CEOs of Mirion Technologies, GS Acquisition Holdings II in Fireside Chat IPO-Edge.com
12:10PM	Why Idexx (IDXX) Could Beat Earnings Estimates Again Zacks
09:59AM	3 Healthcare Stocks That Are Better Than Tesla Right Now Motley Fool
Oct-12-21 07:46PM	Here is What Hedge Funds Think About IDEXX Laboratories, Inc. (IDXX) Insider Monkey
11:50AM	Goldman-Backed Nuclear Analytics: Join CEOs of Mirion Technologies, GS Acquisition Holdings II in Fireside Chat Thursday IPO-Edge.com
Oct-08-21 04:15PM	IDEXX Laboratories to Release 2021 Third Quarter Financial Results PR Newswire
Oct-01-21 01:22PM	Heres Why You Should Consider Investing in IDEXX Laboratories (IDXX) Insider Monkey
10:15AM	Hologic (HOLX) Adds New Products to Omni Hysteroscopy Offering Zacks
Sep-30-21 10:16AM	Thermo Fisher (TMO) Launches Kit for Safer Sample Collection Zacks
Sep-28-21 11:30AM	Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year? Zacks
10:17AM	Globus Medical (GMED) Progresses With ExcelsiusGPS in DBS Zacks
09:03AM	Orthofix (OFIX) Reaches Milestone for M6-C Disc Implants Zacks
Sep-27-21 10:05AM	IDEXX (IDXX) CAG Placement Grows Globally Amid Cost Woes Zacks
Sep-23-21 08:41AM	Cutera, NetEase, West Pharmaceutical, IDEXX Laboratories and Align Tech highlighted as Zacks Bull and Bear of the Day Zacks
Sep-22-21 10:06AM	Bet on These 3 MedTech Growth Stocks for 2021 & Beyond Zacks
Sep-21-21 10:36AM	Here's Why You Should Retain Walgreens (WBA) Stock for Now Zacks
Sep-20-21 08:29AM	Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now Zacks
Sep-17-21 09:25AM	Are Institutions Heavily Invested In IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shares? Simply Wall St.
Sep-16-21 12:50PM	Is IDEXX Laboratories (IDXX) A Smart Long-Term Buy? Insider Monkey
Sep-15-21 06:27AM	Here's Why I Favor the Shares of Zoetis Over 2 Competitors TheStreet.com
Sep-10-21 11:30AM	Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year? Zacks
Sep-07-21 10:37AM	This Pet Health Stock Is Down After Earnings -- Here's Why Motley Fool
10:27AM	Here's Why You Should Invest In Henry Schein (HSIC) Now Zacks
Aug-30-21 01:32PM	Dow Jones Lags Nasdaq, But Apple Stock Hits All-Time High; PayPal, Lululemon, Tesla Lead Nasdaq 100 Investor's Business Daily
12:45PM	Idexx (IDXX) is an Incredible Growth Stock: 3 Reasons Why Zacks
10:53AM	Idexx Laboratories Gets Its Bounce At 50-day Line Investor's Business Daily Video
08:14AM	Dow Jones Futures: Market Rally Shows Broad Strength, Affirm Surges On Amazon Deal; Shopify, Palantir Near Buys Investor's Business Daily
Aug-28-21 08:00AM	Pool, Dexcom Lead Five Stocks Showing Tight, Bullish Action Near Buy Points Investor's Business Daily
Aug-27-21 04:34PM	IBD Stock Of The Day Idexx Spots Multiple Entries As Pet Adoptions Drive Growth Investor's Business Daily
12:55PM	Heres Why You Should Consider Investing in IDEXX Laboratories (IDXX) Insider Monkey
09:19AM	Here's Why You Should Retain Integra (IART) Stock for Now Zacks
09:18AM	Thermo Fisher's (TMO) Oncomine Dx Gets CDx Approval for TIBSOVO Zacks
Aug-24-21 11:30AM	Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year? Zacks
Aug-20-21 06:57PM	Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now Zacks
Aug-18-21 09:33AM	Those who invested in IDEXX Laboratories (NASDAQ:IDXX) five years ago are up 513% Simply Wall St.
08:18AM	Dow Jones Futures: Market Rally Retreats, Tesla, Home Depot, CrowdStrike Hit; Target Falls On Earnings Investor's Business Daily
06:35AM	3 Smartest Healthcare Stocks to Buy With $1,000 Right Now Motley Fool
Aug-17-21 11:47AM	Idexx Tests Support After Run Investor's Business Daily Video
10:13AM	Teleflex (TFX) Rides on UroLift Growth, Hurt by Pandemic Woes Zacks
08:56AM	Time to Focus on IDEXX Laboratories (IDXX) for Strong Earnings Growth Potential Zacks
Aug-11-21 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX) Zacks
Aug-10-21 09:53AM	Thermo Fisher (TMO) Hits a 52-Week High: What's Driving It? Zacks
Aug-09-21 03:30PM	IDEXX Laboratories to Host Virtual Investor Day PR Newswire
Aug-05-21 11:30AM	Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year? Zacks
Jul-30-21 02:30PM	IDEXX Laboratories, inc (IDXX) Q2 2021 Earnings Call Transcript Motley Fool
09:55AM	IDEXX (IDXX) Q2 Earnings Beat Estimates, 2021 Guidance Up Zacks
07:45AM	Idexx Laboratories (IDXX) Q2 Earnings and Revenues Top Estimates Zacks
06:30AM	IDEXX Laboratories Announces Second Quarter Results PR Newswire
Jul-29-21 09:13AM	Why IDEXX Laboratories (IDXX) Might Surprise This Earnings Season Zacks
Jul-28-21 06:20AM	Should JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) Be on Your Investing Radar? Zacks
Jul-27-21 07:28AM	What's in Store for IDEXX Laboratories (IDXX) in Q2 Earnings? Zacks
Jul-23-21 03:00PM	Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy? Zacks
Jul-22-21 05:55AM	3 Surprising Stocks That Have Crushed the Market so Far This Year Motley Fool
Jul-20-21 12:10PM	Can Idexx (IDXX) Keep the Earnings Surprise Streak Alive? Zacks
08:04AM	How Millennials And Gen Z Are Bringing Animal Health Stocks To New Highs Investor's Business Daily Video
Jul-19-21 08:30AM	Here's How Much a $1000 Investment in Idexx Laboratories Made 10 Years Ago Would Be Worth Today Zacks
03:48AM	IDEXX Laboratories (NASDAQ:IDXX) Looks To Prolong Its Impressive Returns Simply Wall St.
Jul-07-21 09:02AM	IDEXX Laboratories (IDXX) Hits 52-Week High: What's Driving It? Zacks
Jul-06-21 08:13AM	Why Idexx Laboratories Gained 13% in June Motley Fool
Jul-05-21 07:51AM	LabCorp (LH) Expands Testing Portfolio With the Launch of CDx Zacks
Jun-30-21 04:05PM	IDEXX Laboratories to Release 2021 Second Quarter Financial Results PR Newswire
Jun-29-21 07:29AM	Pandemic Boosts Animal Health Spending: 4 Stocks to Buy Zacks
06:48AM	Globus Medical (GMED) Hits New 52-Week High: What's Driving It? Zacks
Jun-25-21 07:12AM	NEOGEN (NEOG) Enhances Aquaculture Genotyping With New Pact Zacks
Jun-24-21 10:28AM	LabCorp (LH), Molecular Loop Team Up for COVID-19 Test Research Zacks
06:53AM	Hologic (HOLX) Gets European Nod for Aptima CMV Quant Assay Zacks
Jun-23-21 11:30AM	Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year? Zacks
09:43AM	Quest Diagnostics (DGX) Unveils Corporate Responsibility Report Zacks
07:42AM	Medtronic (MDT) Gets Expanded FDA Nod for Cryoablation Catheters Zacks
Jun-22-21 10:03AM	Illumina's (ILMN) NovaSeq Adoption Aids, Margin Woe Stays Zacks
Jun-21-21 11:32AM	Hedge Funds Have Never Been This Bullish On IDEXX Laboratories, Inc. (IDXX) Insider Monkey
08:30AM	Thermo Fisher's (TMO) New Launch Boosts Preclinical Development Zacks
Jun-18-21 07:43AM	Bruker (BRKR) Updates 2021 Outlook, Issues Medium-Term View Zacks
Jun-15-21 07:32AM	Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now Zacks
Jun-14-21 10:38AM	Medtronic (MDT) Progresses in SCS With FDA Nod for Vanta Zacks
Jun-11-21 05:45PM	Idexx Stock Clears Key Benchmark Amid Strong Profit, Sales Growth; Expands Via Cloud Software Buyout Investor's Business Daily
10:41AM	Henry Schein (HSIC) Enhances Dental Practices With New Deal Zacks
Jun-10-21 10:25AM	Hologic (HOLX) Acessa Procedure Now Covered by Cigna Insurance Zacks
Jun-09-21 08:12AM	CVS Health (CVS) Deploys Time-Delay Safes in Georgia Pharmacies Zacks
08:11AM	Up 100% in a Year, Can This Animal Health Stock Keep Climbing? Motley Fool
Jun-08-21 10:14AM	Medtronic (MDT) Progresses in Neuromodulation on New FDA Nod Zacks
07:11AM	Abbott (ABT) Confirms Capacity to Support MCS Devices Demand Zacks
06:59AM	Here's Why You Should Retain CVS Health (CVS) in Your Portfolio Zacks
Jun-07-21 05:50PM	Idexx Laboratories (IDXX) Gains As Market Dips: What You Should Know Zacks
07:40AM	STERIS (STE) Expands Product Suite With New Acquisition Zacks
Jun-04-21 11:30AM	Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year? Zacks
08:21AM	IDEXX (IDXX) Acquires ezyVet to Boost Practice Management Arm Zacks
04:12AM	Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)? Simply Wall St.
Jun-03-21 11:31AM	Why Is Idexx (IDXX) Up 3.3% Since Last Earnings Report? Zacks
08:47AM	Why IDEXX (IDXX) Could Be an Impressive Growth Stock Zacks
Jun-02-21 04:53PM	IDEXX Acquires ezyVet PR Newswire
04:25PM	IDEXX Acquires ezyVet CNW Group
06:27AM	This News Could Boost Idexx Labs' Earnings for Years to Come Motley Fool
May-28-21 04:19PM	Dow Jones Gains; Biden Says This On Economy Despite Inflation; AMC Stock Trades Wildly Investor's Business Daily
04:06PM	Tech Leader Idexx Labs Briefly Breaks Out On Road To New Record High Investor's Business Daily
May-26-21 11:45AM	IDEXX Laboratories to Present at Stifel Conference and Announces 2021 Virtual Investor Day PR Newswire
May-25-21 04:27PM	IBD Stock Of The Day: 'Dog'Nostics' Leader Idexx Labs Barks At Buy Point Investor's Business Daily
11:52AM	Idexx Labs Nears Buy Point Investor's Business Daily Video
May-19-21 08:00AM	Energy Stocks, Veterinary Leaders Near Buy Points In CAN SLIM-Based Screen Investor's Business Daily

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Claflin Bruce L.	Director	Oct 11	Option Exercise	160.28	1,921	307,898	1,921	Oct 13 05:01 PM
Turner Kathy V	Senior Vice President	Aug 31	Option Exercise	79.54	1,256	99,902	4,131	Sep 02 05:03 PM
Turner Kathy V	Senior Vice President	Aug 30	Option Exercise	79.54	2,250	178,965	5,125	Aug 31 05:01 PM
Turner Kathy V	Senior Vice President	Aug 30	Sale	687.22	2,250	1,546,250	2,875	Aug 31 05:01 PM
Turner Kathy V	Senior Vice President	Aug 27	Option Exercise	64.24	276	17,730	3,151	Aug 31 05:01 PM
Turner Kathy V	Senior Vice President	Aug 27	Sale	678.00	276	187,128	2,875	Aug 31 05:01 PM
MAZELSKY JONATHAN JAY	President & CEO	Aug 16	Sale	673.33	1,263	850,411	49,427	Aug 17 05:02 PM
MAZELSKY JONATHAN JAY	President & CEO	Aug 13	Sale	675.71	4,737	3,200,852	50,690	Aug 17 05:02 PM
JUNIUS DANIEL M	Director	Aug 10	Option Exercise	85.00	2,402	204,170	5,298	Aug 12 05:01 PM
Hunt Nimrata	Executive Vice President	Aug 10	Option Exercise	90.32	1,106	99,896	9,212	Aug 12 05:00 PM
JUNIUS DANIEL M	Director	Aug 10	Sale	679.58	2,402	1,632,355	2,896	Aug 12 05:01 PM
SZOSTAK M ANNE	Director	Aug 06	Sale	687.87	3,000	2,063,616	7,217	Aug 09 05:02 PM
Hunt Nimrata	Executive Vice President	Aug 05	Option Exercise	137.90	538	74,190	8,644	Aug 09 05:00 PM
MAZELSKY JONATHAN JAY	President & CEO	Aug 05	Option Exercise	0.00	385	0	55,606	Aug 09 05:01 PM
MCKEON BRIAN P	Executive VP & CFO	Aug 05	Option Exercise	0.00	192	0	26,404	Aug 09 05:01 PM
Hunt Nimrata	Executive Vice President	Aug 05	Sale	703.00	538	378,214	8,106	Aug 09 05:00 PM
TWIGGE GIOVANI	Senior Vice President	Aug 04	Option Exercise	207.68	10,102	2,097,987	28,549	Aug 05 05:02 PM
TWIGGE GIOVANI	Senior Vice President	Aug 04	Sale	700.35	11,421	7,998,668	17,128	Aug 05 05:02 PM
Lane Michael	Executive Vice President	Aug 03	Option Exercise	114.59	6,999	802,037	10,646	Aug 05 05:01 PM
TWIGGE GIOVANI	Senior Vice President	Aug 03	Option Exercise	131.08	10,350	1,356,705	27,321	Aug 05 05:02 PM
TWIGGE GIOVANI	Senior Vice President	Aug 03	Sale	695.54	8,874	6,172,232	18,447	Aug 05 05:02 PM
Lane Michael	Executive Vice President	Aug 03	Sale	691.62	6,999	4,840,670	3,647	Aug 05 05:01 PM
AYERS JONATHAN W	Director	May 28	Option Exercise	79.54	9,460	752,448	654,161	Jun 01 06:00 PM
POLEWACZYK JAMES F	Executive Vice President	May 28	Option Exercise	67.85	10,000	678,500	29,915	Jun 01 06:01 PM
POLEWACZYK JAMES F	Executive Vice President	May 28	Sale	561.91	10,000	5,619,057	19,915	Jun 01 06:01 PM
Turner Kathy V	Senior Vice President	May 28	Sale	558.44	2,000	1,116,884	2,886	Jun 01 06:01 PM
AYERS JONATHAN W	Director	May 28	Sale	562.26	9,460	5,318,989	644,701	Jun 01 06:00 PM
AYERS JONATHAN W	Director	May 25	Option Exercise	79.54	5,000	397,700	658,701	May 26 05:30 PM
AYERS JONATHAN W	Director	May 25	Sale	552.17	5,000	2,760,842	653,701	May 26 05:30 PM
AYERS JONATHAN W	Director	May 24	Option Exercise	79.54	5,000	397,700	658,701	May 26 05:30 PM
AYERS JONATHAN W	Director	May 24	Sale	546.98	5,000	2,734,894	653,701	May 26 05:30 PM
Turner Kathy V	Senior Vice President	May 24	Sale	546.24	2,900	1,584,100	4,866	May 26 05:31 PM
JUNIUS DANIEL M	Director	May 21	Option Exercise	85.00	2,500	212,500	5,386	May 24 06:15 PM
JUNIUS DANIEL M	Director	May 21	Sale	539.57	2,500	1,348,918	2,886	May 24 06:15 PM
Turner Kathy V	Senior Vice President	May 21	Sale	545.00	1,000	545,000	7,766	May 24 06:15 PM
AYERS JONATHAN W	Director	May 20	Option Exercise	79.54	5,000	397,700	658,701	May 24 06:14 PM
Turner Kathy V	Senior Vice President	May 20	Sale	537.50	2,000	1,075,000	8,766	May 24 06:15 PM
AYERS JONATHAN W	Director	May 20	Sale	537.06	5,000	2,685,324	653,701	May 24 06:14 PM
AYERS JONATHAN W	Director	May 18	Option Exercise	79.54	7,632	607,049	661,333	May 20 05:33 PM
AYERS JONATHAN W	Director	May 18	Sale	528.01	7,632	4,029,809	653,701	May 20 05:33 PM
AYERS JONATHAN W	Director	May 10	Sale	541.02	512	277,000	653,701	May 12 07:47 PM
TWIGGE GIOVANI	Senior Vice President	Feb 26	Option Exercise	67.85	3,227	218,952	16,950	Mar 01 05:06 PM
POLEWACZYK JAMES F	Executive Vice President	Feb 25	Option Exercise	67.85	1,476	100,147	19,903	Mar 01 05:05 PM
HENDERSON REBECCA M	Director	Feb 23	Option Exercise	160.28	3,046	488,213	17,742	Feb 25 07:35 PM
AYERS JONATHAN W	Director	Feb 23	Option Exercise	67.85	1,476	100,147	654,213	Feb 25 07:34 PM
HENDERSON REBECCA M	Director	Feb 23	Sale	513.41	3,046	1,563,840	14,696	Feb 25 07:35 PM
JUNIUS DANIEL M	Director	Feb 22	Option Exercise	82.42	1,898	156,427	4,773	Feb 24 05:00 PM
Underberg Sharon E.	SVP, Gen. Counsel & Secretary	Feb 22	Option Exercise	206.94	483	99,952	1,878	Feb 24 05:01 PM
MAZELSKY JONATHAN JAY	President & CEO	Feb 22	Option Exercise	67.85	1,475	100,079	55,697	Feb 24 05:01 PM
JUNIUS DANIEL M	Director	Feb 22	Sale	538.57	1,898	1,022,207	2,875	Feb 24 05:00 PM
MCKEON BRIAN P	Executive VP & CFO	Feb 18	Option Exercise	67.85	1,474	100,011	26,188	Feb 19 05:01 PM
AYERS JONATHAN W	Director	Feb 18	Option Exercise	79.54	1,000	79,540	653,737	Feb 22 06:00 PM
AYERS JONATHAN W	Director	Feb 18	Sale	555.56	1,000	555,561	652,737	Feb 22 06:00 PM
MAZELSKY JONATHAN JAY	President & CEO	Feb 17	Option Exercise	52.00	25,000	1,300,000	68,090	Feb 19 05:00 PM
MAZELSKY JONATHAN JAY	President & CEO	Feb 17	Sale	537.21	13,868	7,449,969	54,222	Feb 19 05:00 PM
Claflin Bruce L.	Director	Feb 16	Option Exercise	97.05	7,027	681,985	7,331	Feb 18 07:26 PM
Claflin Bruce L.	Director	Feb 16	Sale	536.91	7,331	3,936,089	0	Feb 18 07:26 PM
Lane Michael	Executive Vice President	Feb 16	Sale	545.00	850	463,250	3,624	Feb 17 07:31 PM
MCKEON BRIAN P	Executive VP & CFO	Feb 16	Sale	539.58	1,307	705,231	24,714	Feb 17 07:33 PM
TWIGGE GIOVANI	Senior Vice President	Feb 14	Option Exercise	0.00	1,126	0	14,061	Feb 17 07:35 PM
MCKEON BRIAN P	Executive VP & CFO	Feb 14	Option Exercise	0.00	2,642	0	27,356	Feb 17 07:33 PM
POLEWACZYK JAMES F	Executive Vice President	Feb 14	Option Exercise	0.00	989	0	18,684	Feb 17 07:34 PM
Turner Kathy V	Senior Vice President	Feb 14	Option Exercise	0.00	987	0	11,142	Feb 17 07:34 PM
MAZELSKY JONATHAN JAY	President & CEO	Feb 14	Option Exercise	0.00	3,110	0	44,537	Feb 17 07:31 PM
Hunt Nimrata	Executive Vice President	Feb 14	Option Exercise	0.00	714	0	8,299	Feb 17 07:30 PM
Lane Michael	Executive Vice President	Feb 14	Option Exercise	0.00	984	0	4,768	Feb 17 07:31 PM
Underberg Sharon E.	SVP, Gen. Counsel & Secretary	Feb 14	Option Exercise	0.00	700	0	1,603	Feb 17 07:35 PM
Vandebroek Sophie V.	Director	Feb 12	Option Exercise	160.28	3,046	488,213	6,367	Feb 16 05:00 PM
Vandebroek Sophie V.	Director	Feb 12	Sale	538.20	3,046	1,639,357	3,321	Feb 16 05:00 PM
SZOSTAK M ANNE	Director	Feb 04	Option Exercise	74.78	11,876	888,128	11,876	Feb 08 06:05 PM
SZOSTAK M ANNE	Director	Feb 04	Sale	489.71	11,876	5,815,816	0	Feb 08 06:05 PM
TWIGGE GIOVANI	CORPORATE VICE PRESIDENT	Nov 30	Option Exercise	67.85	12,801	868,548	25,723	Dec 02 05:01 PM
TWIGGE GIOVANI	CORPORATE VICE PRESIDENT	Nov 30	Sale	456.49	12,801	5,843,566	12,922	Dec 02 05:01 PM
HENDERSON REBECCA M	Director	Nov 10	Option Exercise	85.00	5,902	501,670	20,598	Nov 12 05:01 PM
HENDERSON REBECCA M	Director	Nov 10	Sale	435.91	5,902	2,572,742	14,696	Nov 12 05:01 PM
MAZELSKY JONATHAN JAY	President & CEO	Nov 06	Option Exercise	69.68	2,868	199,846	41,413	Nov 09 05:01 PM
MCKEON BRIAN P	Executive VP & CFO	Nov 06	Sale	476.25	10,000	4,762,456	18,050	Nov 10 07:02 PM
AYERS JONATHAN W	Director	Nov 06	Sale	470.01	6,470	3,040,938	709,991	Nov 10 07:01 PM
MAZELSKY JONATHAN JAY	President & CEO	Nov 05	Sale	469.31	5,206	2,443,254	39,145	Nov 09 05:01 PM
Hunt Nimrata	Executive Vice President	Nov 05	Sale	470.08	2,098	986,228	7,571	Nov 06 05:07 PM
AYERS JONATHAN W	Director	Nov 05	Sale	467.16	15,134	7,069,988	716,461	Nov 06 05:06 PM
MCKEON BRIAN P	Executive VP & CFO	Nov 04	Option Exercise	79.54	36,216	2,880,621	60,916	Nov 06 05:07 PM
AYERS JONATHAN W	Director	Nov 04	Sale	471.90	11,440	5,398,561	731,595	Nov 06 05:06 PM
MCKEON BRIAN P	Executive VP & CFO	Nov 04	Sale	471.44	36,216	17,073,801	24,700	Nov 06 05:07 PM
Lane Michael	Executive Vice President	Nov 03	Option Exercise	70.92	2,851	202,184	5,074	Nov 05 07:51 PM
Lane Michael	Executive Vice President	Nov 03	Sale	443.00	1,304	577,670	3,770	Nov 05 07:51 PM
AYERS JONATHAN W	Director	Nov 03	Sale	443.63	10,432	4,627,955	743,035	Nov 04 05:25 PM
AYERS JONATHAN W	Director	Nov 02	Sale	433.01	10,000	4,330,085	753,467	Nov 04 05:25 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience